索引超出了数组界限。 文章摘要
|本期目录/Table of Contents|

[1]朱天宇,张瑞岩.左心室重建术的发展过程[J].国际心血管病杂志,2016,03:133-138.
点击复制

左心室重建术的发展过程(PDF)

《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]

期数:
2016年03期
页码:
133-138
栏目:
综述
出版日期:
2016-05-20

文章信息/Info

Title:
-
作者:
朱天宇; 张瑞岩
200025 上海交通大学医学院附属瑞金医院心内科
Author(s):
-
关键词:
心力衰竭; 左心室室壁瘤; 左心室重建术; 左心室重建装置; 左心室隔离装置
Keywords:
-
分类号:
-
DOI:
10.3969/j.issn.1673-6583.2016.03.002
文献标识码:
-
摘要:
心力衰竭(心衰)是一种进展性疾病,传统药物治疗无法逆转心衰进展、心室扩大的过程。左心室重建术是一种可以降低心室容积、重塑心室几何结构的治疗方法。随着对心脏结构认知的深入和介入技术的不断发展,经皮左心室重建术成为一种可行的治疗心衰的方法。该文主要介绍左心室重建术的发展历程及研究进展。
Abstract:
-

参考文献/References

[1] 顾东风,黄广勇,何 江,等.中国心力衰竭流行病学调查及其患病率[J].中华心血管杂志,2003,31(1):3-6.
[2] 陈 晨,金惠根.慢性心力衰竭治疗进展[J].国际心血管病杂志,2015,42(4):231-234.
[3] 王 君,郑 兴.心力衰竭新药的临床研究[J].国际心血管病杂志,2014,41(2):72-74.
[4] Chen J, Normand SL, Wang Y, et al. National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries, 1998-2008[J]. JAMA. 2011, 306(15):1669-1678.
[5] Krum H, Teerlink JR. Medical therapy for chronic heart failure[J]. Lancet, 2011, 378(9792): 713-721.
[6] Konstam MA, Kramer DG, Patel AR, et al. Left ventricular remodeling in heart failure: current concepts in clinical significance and assessment[J]. JACC Cardiovasc Imaging. 2011,4(1):98-108.
[7] Moriarty TF. The law of Laplace. Its limitations as a relation for diastolic pressure, volume, or wall stress of the left ventricle[J]. Circ Res, 1980,46(3):321-331.
[8] Torrent-Guasp F, Ballester M, Buckberg GD, et al. Spatial orientation of the ventricular muscle band:physiologic contribution and surgical implications[J]. J Thorac Cardiovasc Surg, 2001,122(2):389-392.
[9] Bolognese L, Neskovic AN, Parodi G, et al. Left ventricular remodeling after primary coronary angioplasty: patterns of left ventricular dilation and long-term prognostic implications[J]. Circulation, 2002,106(18):2351-2357.
[10] Dor V, Saab M, Coste P, et al. Left ventricular aneurysm: a new surgical approach[J]. J Thorac Cardiovasc Surg, 1989,37(1):11-19.
[11] Athanasuleas CL, Buckberg GD, Stanley AW, et al. Surgical ventricular restoration in the treatment of congestive heart failure due to post-infarction ventricular dilation[J]. J Am Coll Cardiol, 2004,44(7):1439-1445.
[12] Jones RH, Velazquez EJ, Michler RE, et al. Coronary bypass surgery with or without surgical ventricular reconstruction[J]. N Engl J Med, 2009,360(17):1705-1717.
[13] Dor V, Civaia F, Alexandrescu C, et al. Favorable effects of left ventricular reconstruction in patients excluded from the Surgical Treatments for Ischemic Heart Failure(STICH)trial[J]. J Thorac Cardiovasc Surg, 2011,141(4):905-916.
[14] Batista RJ, Santos JL, Takeshita N, et al. Partial left ventriculectomy to improve left ventricular function in end-stage heart disease[J]. J Card Surg, 1996,11(2):96-97.
[15] Starling RC, McCarthy PM, Buda T, et al. Results of partial left ventriculectomy for dilated cardiomyopathy: hemodynamic, clinical and echocardiographic observations[J]. J Am Coll Cardiol, 2000,36(7):2098-2103.
[16] Buckberg GD, Coghlan HC, Torrent-Guasp F. The structure and function of the helical heart and its buttress wrapping. VI. Geometric concepts of heart failure and use for structural correction[J]. Semin Thorac Cardiovasc Surg, 2001,13(4):386-401.
[17] Isomura T, Horii T, Suma H, et al. Septal anterior ventricular exclusion operation(Pacopexy)for ischemic dilated cardiomyopathy: treat form not disease[J].Eur J Cardiothorac Surg, 2006. 29(Suppl 1): S245-S250.
[18] Suma H, Horii T, Isomura T, et al. A new concept ofventricular restoration for nonischemic dilated cardiomyopathy[J]. Eur J Cardiothorac Surg, 2006,29(Suppl 1): S207-S212.
[19] Walsh RG. Design and features of the Acorn CorCap Cardiac Support Device: the concept of passive mechanical diastolic support[J]. Heart Fail Rev, 2005,10(2):101-107.
[20] Mann DL, Kubo SH, Sabbah HN, et al. Beneficial effects of the CorCap cardiac support device: five-year results from the Acorn Trial[J]. J Thorac Cardiovasc Surg, 2012,143(5):1036-1042.
[21] Takagaki M, McCarthy PM, Ochiai Y, et al. Novel device to change left ventricular shape for heart failure treatment: Device design and implantation procedure[J]. ASAIO J, 2001,47(3):244-248.
[22] Fukamachi K, McCarthy PM. Initial safety and feasibility clinical trial of the myosplint device[J]. J Card Surg, 2005,20(6):S43-S47.
[23] Grossi EA, Patel N, Woo YJ, et al. Outcomes of the RESTOR-MV Trial(randomized evaluation of a surgical treatment for off-pump repair of the mitral valve)[J]. J Am Coll Cardiol, 2010,56(24):1984-1993.
[24] Pedersen WR, Block P, Leon M, et al. iCoapsys mitral valve repair system: Percutaneous implantation in an animal model[J]. Catheter Cardiovasc Interv, 2008,72(1):125-131.
[25] Magovern JA, Teekell-Taylor L, Mankad S, et al. Effect of a flexible ventricular restraint device on cardiac remodeling after acute myocardial infarction[J]. ASAIO J, 2006,52(2):196-200.
[26] Costanzo MR, Ivanhoe RJ, Kao A, et al. Prospective evaluation of elastic restraint to lessen the effects of heart failure(PEERLESS-HF)trial[J]. J Card Fail, 2012,18(6):446-458.
[27] Faria R, Melica B, Pires-Morais G, et al. New less invasive ventricular reconstruction technique in the treatment of ischemic heart failure[J]. Rev Port Cardiol, 2014,33(7-8):469.
[28] Sabbah HN, Wang M, Gupta RC, et al. Augmentation of left ventricular wall thickness with alginate hydrogel implants improves left ventricular function and prevents progressive remodeling in dogs with chronic heart failure[J]. JACC Heart Fail, 2013,1(3): 252-258.
[29] Anker SD, Coats AJ, Cristian G, et al. A prospective comparison of alginate-hydrogel with standard medical therapy to determine impact on functional capacity and clinical outcomes in patients with advanced heart failure(AUGMENT-HF trial)[J]. Eur Heart J, 2015,36(34):2297-2309.
[30] Mann DL, Lee RJ, Coats AJ, et al. One-year follow-up results from AUGMENT-HF: a multicentre randomized controlled clinical trial of the efficacy of left ventricular augmentation with Algisyl in the treatment of heart failure[J]. Eur J Heart Fail, 2015,Nov 11.[Epub ahead of print].
[31] CilingirogluM, Rollefson WA, MegoD. Percutaneous implantation of a parachute device for treatment of ischemic heart failure[J]. Cardiovasc Revasc Med, 2013, 14(4): 236-240.
[32] Nikolic SD, Khairkhahan A, Ryu M, et al. Percutaneous implantation of an intraventricular device for the treatment of heart failure: experimental results and proof of concept[J]. J Card Fail, 2009,15(9):790-797.
[33] Otasevic P, Sagic D, Antonic Z, et al. First-in-man implantation of left ventricular partitioning device in a patient with chronic heart failure: twelve-month follow-up[J]. J Card Fail, 2007,13(7):517-520.
[34] Costa MA, Mazzaferri EL, Sievert H, et al.Percutaneous ventricular restoration using the parachute device in patients with ischemic heart failure: three-year outcomes of the PARACHUTE first-in-human study[J]. Circ Heart Fail, 2014,7(5):752-758.
[35] Schmidt T, Frerker C, Thielsen T, et al. New evidence for favourable effects on haemodynamics and ventricular performance after Parachute implantation in humans[J]. Eur J Heart Fail, 2014,16(10):1112-1119.
[36] Costa MA, Pencina M, Nikolic S, et al. The PARACHUTE Ⅳ trial design and rationale: percutaneous ventricular restoration using the parachute device in patients with ischemic heart failure and dilated left ventricles[J]. Am Heart J, 2013,165(4):531-536.
[37] 马 为,洪 涛,李建平,等.经皮心室重建术——附两例病例报告[J].中国介入心脏病学杂志,2013,21(5): 274-277.
[38] 丁风华,方跃华,杨文洁,等.经皮左心室重建术治疗前壁心肌梗死后室壁瘤合并心功能不全一例[J].介入放射学杂志,2014,23(10):886-888.
[39] Ladich E, Otsuka F, Virmani R. A pathologic study of explanted parachute devices from seven heart failure patients following percutaneous ventricular restoration[J]. Catheter Cardiovasc Interv, 2014,83(4):619-630.
[40] Lauschke J, Schneider R, Bansch D. Ventricular tachycardia ablation in a patient with a parachute device: a decent word of warning[J]. Europace, 2014,16(2):207.
[41] Oliveira GH, Al-Kindi SG, Bezerra HG, et al. Left ventricular restoration devices[J]. J Cardiovasc Transl Res, 2014,7(3):282-291.

备注/Memo

备注/Memo:
通信作者:张瑞岩,Email:zhangruiyan@263.net
更新日期/Last Update: 2016-05-20